Rapamycin decreases tau phosphorylation at Ser214 through regulation of cAMP-dependent kinase

Neurochemistry International

Volumn 62, Issue 4, 2013, Pages 458-467

  Liu, Yudong ^a   Su, Ying ^a   Wang, Jiajia ^a   Sun, Shenggang ^a   Wang, Tao ^a   Qiao, Xian ^a   Run, Xiaoqin ^a   Li, Hui ^b   Liang, Zhihou ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Alzheimer's disease; cAMP dependent kinase; Extracellular signal regulated kinase; Mammalian target of rapamycin (mTOR); Rapamycin; Tau

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CYCLIC AMP DEPENDENT PROTEIN KINASE; RAPAMYCIN; TAU PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME REGULATION; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

CELL LINE, TUMOR; CYCLIC AMP-DEPENDENT PROTEIN KINASES; HUMANS; PHOSPHORYLATION; SERINE; SIROLIMUS; TAU PROTEINS;

MAMMALIA; RODENTIA;

EID: 84874607578     PISSN: 01970186     EISSN: 18729754     Source Type: Journal    
DOI: 10.1016/j.neuint.2013.01.014     Document Type: Article

References (61)

1. C. Ballatore, V.M. Lee, and J.Q. Trojanowski Tau-mediated neurodegeneration in Alzheimer's disease and related disorders Nat. Rev. Neurosci. 8 2007 663 672
2. J.R. Bardales, U. Hellman, and J.A. Villamarin CK2-mediated phosphorylation of a type II regulatory subunit of cAMP-dependent protein kinase from the mollus Mytilus galloprovincialis Arch. Biochem. Biophys. 461 2007 130 137
3. Z. Berger, B. Ravikumar, F.M. Menzies, L.G. Oroz, B.R. Underwood, M.N. Pangalos, I. Schmitt, U. Wullner, B.O. Evert, C.J. O'Kane, and D.C. Rubinsztin Rapamycin alleviates toxicity of different aggregate-prone proteins Hum. Mol. Genet. 15 2006 433 442
4. R.K. Braun, P.R. Vulliet, D.A. Carbonaro-Hall, and F.L. Hall Phosphorylation of RII subunit and attenuation of cAMP-dependent protein kinase activity by proline-directed protein kinase Arch. Biochem. Biophys. 289 1991 187 191
5. A. Caccamo, S. Majumder, A. Richardson, R. Strong, and S. Oddo Molecular interplay between mammalian target of rapamycin (mTOR), amyloid-beta, and tau: effects on cognitive impairments J. Biol. Chem. 285 2010 13107 13120
6. S. Carloni, S. Girelli, C. Scopa, G. Buonocore, M. Longini, and W. Balduini Activation of autophagy and Akt/CREB signaling play an equivalent role in the neuroprotective effect of rapamycin in neonatal hypoxia-ischemia Autophagy 6 2010 366 377
7. C.R. Carlson, O. Witczak, L. Vossebein, J.C. Labbe, B.S. Shalhegg, G. Keryer, F.W. Herberg, P. Collas, and K. Tasken CDK1-mediated phosphorylation of the RIIα regulatory subunit of PKA works as a molecular switch that promotes dissociation of RIIα from centrosomes at mitosis J. Cell. Sci. 114 2001 3243 3254
8. M. Diskar, H.M. Zenn, A. Kaupisch, A. Prinz, and F.W. Herberg Molecular basis for isoform-specific autoregulation of protein kinase A Cell. Signal. 19 2007 2024 2034
9. Z. Freyberg, S.J. Ferrando, and J.A. Javitch Roles of Akt/GSK-3 and Wnt signaling pathways in schizophrenia and antipsychotic drug action Am. J. Psychiatry 167 2010 388 396
10. A. Giralt, A. Saavedra, O. Carreton, X. Xifro, J. Alberch, and E. Perez-Navarro Increased PKA signaling disrupts recognition memory and spatial memory: role in Huntington's disease Hum. Mol. Genet. 20 2011 4232 4247
11. C.X. Gong, I. Grundke-Iqbal, and K. Iqbal Targeting tau protein in Alzheimer's disease Drugs Aging 27 2010 351 365
12. J. Granot, A. Mildvan, S. Hiyama, H. Kondo, and E.T. Kaiser Magnetic resonance studies of the effect of the regulatory subunit on metal and substrate binding to the catalytic subunit of bovine heart protein kinase J. Biol. Chem. 255 1980 4569 4573
13. R.J. Griffin, A. Moloney, M. Kelliher, J.A. Johnson, R. Ravid, P. Dockery, R. O'Connor, and C. O'Neil Activation of Akt/PKB, increased phosphorylation of Akt substrates and loss and altered distribution of Akt and PTEN are features of Alzheimer's disease pathology J. Neurochem. 93 2005 105 117
14. S. Gupta, A.R. Ramjaun, P. Haiko, Y. Wang, P.H. Warne, B. Nicke, E. Nye, G. Stamp, K. Alitalo, and J. Downward Binding of Ras to phosphoinositide 3-kinase p110 alpha is required for Ras-driven tumorigenesis in mice Cellular 129 2007 957 968
15. C.R. Guthrie, and B.C. Kraemer Proteasome inhibition drives HDAC6-dependent recruitment of tau to aggresomes J. Mol. Neurosci. 45 2011 32 41
16. T. Hagen, and A. Vidal-Puig Characterisation of the phosphorylation of β-catenin at the GSK-3 priming site Ser45 Biochem. Biophy. Res. Commun. 294 2002 324 328
17. D.P. Hanger, B.H. Anderton, and W. Noble Tau phosphorylation: the therapeutic challenge for neurodegenerative disease Trends. Mol. Med. 15 2009 112 119
18. B.A. Hemmings, A. Aitken, P. Cohen, M. Rymond, and F. Hofmann Phosphorylation of the type-II regulatory subunit of cyclic-AMP-dependent protein kinase by glycogen synthase kinase 3 and glycogen synthase kinase 5 Eur. J. Biochem. 127 1982 473 481
19. A. Huber, B. Bodenmiller, A. Uotila, M. Stahl, S. Wanka, B. Gerrits, R. Aebersold, and R. Loewith Characterization of the rapamycin sensitive phosphoproteome reveals that Sch9 is a central coordinator of protein synthesis Genes. Dev. 23 2009 1929 1943
20. E. Jacinto, and A. Lorberg TOR regulation of AGC kinase in yeast and mammals Biochem. J. 410 2008 19 37
21. G. Keryer, Z. Luo, J.C. Cavadore, J. Erlichman, and M. Bornens Phosphorylation of the regulatory subunit of type II beta cAMP-dependent protein kinase by cyclin B/p34cdc2 kinase impairs its binding to microtubule-associated protein 2 Prog. Natl. Acad. Sci. USA 90 1993 5418 5422
22. M.O. Kim, Y.J. Lee, J.H. Park, J.M. Ryu, S.P. Yun, and H.J. Han PKA and cAMP stimulate proliferation of mouse embryonic stem cells by elevating GLUT1 expression mediated by the NF-kB and CREB/CBP signaling pathways Biochim. Biophys. Acta 1820 2012 1636 1646
23. V. Leinonen, A.M. Koivisto, S. Savolainen, J. Rummukainen, J.N. Tamminen, T. Tillgren, S. Vainikka, O.T. Pyykko, M. Fraunberg, T. Pirttila, J.E. Jaaskelainen, H. Soininen, J. Rinne, and I. Alafuzoff Amyloid and tau proteins in cortical brain biopsy and Alzheimer's disease Ann. Neurol. 68 2010 446 453
24. P. Laprise, M.J. Lanqlois, M.J. Boucher, C. Jobin, and N. Rivard Down-regulation of MEK/ERK signaling by E-cadherin-dependent PI3K/Akt pathway in differentiating intestinal epithelial cells J. Cell. Physiol. 199 2004 32 39
25. + persons reverses the decrease in TLR-4-mediated TNF-α release through prolongation of MAPK pathway activation J. Immunol. 187 2011 6052 6058
26. S.J. Liu, J.Y. Zhang, H.L. Li, Z.Y. Fang, Q. Wang, H.M. Deng, C.X. Gong, I. Grundke-Iqbal, L.K. Iqba, and J.Z. Wang Tau becomes a more favorable substrate for GSK-3 when it is prephosphorylated by PKA in rat brain J. Biol. Chem. 279 2004 50078 50088
27. Z. Liang, F. Liu, I. Grundke-Iqbal, K. Iqbal, and C.X. Gong Downregulation of cAMP-dependent protein kinase by over-activated calpain in Alzheimer disease brain J. Neurochem. 103 2007 2462 2470
28. G. Lindwall, and R.D. Cole The purification of tau protein and the occurrence of two phosphorylation states of tau in brain J. Biol. Chem. 259 1984 12241 12245
29. S.J. Liu, J.Y. Zhang, H.L. Li, Z.Y. Fang, Q. Wang, H.M. Deng, C.X. Gong, I. Grundke-Iqbal, K. Iqbal, and J.Z. Wang Tau becomes a more favorable substrate for GSK-3 when it is prephosphorylated by PKA in rat brain J. Biol. Chem. 279 2004 50078 50088
30. X.A. Liu, K. Liao, R. Liu, H.H. Wang, Y. Zhang, Q. Zhang, Q. Wang, H.L. Li, and J.Z. Wang Tau dephosphorylation potentiates apoptosis by mechanisms involving a failed dephosphorylation/activation of Bcl-2 J. Alzheim. Dis. 19 2010 953 962
31. Y. Liu, Y. Su, S. Sun, T. Wang, X. Qiao, H. Li, X. Run, and Z. Liang Human tau may modify glucocorticoids-mediated regulation of cAMP-dependent kinase and phosphorylated cAMP response element binding protein Neurochem. Res. 37 2012 935 947
32. L. Ma, J. Teruya-Feldstein, P. Bonner, R. Bernardi, D.N. Franz, D. Witte, C. Cordon-Cardo, and P.P. Pandolfi Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer Cancer Res. 67 2007 7112 7162
33. S. Majumder, A. Richardson, R. Strong, and S. Oddo Inducing autophagy by rapamycin before, but not after, the formation of plaques and tangles ameliorates cognitive deficits PLoS One 6 9 2011 e25416
34. S. Manni, J.H. Mauban, C.W. Ward, and M. Bond Phosphorylaiton of the cAMP-dependent protein kinase (PKA) regulatory subunit modulates PKA-AKAP interaction, substrate phosphorylation, and calcium signaling in cardiac cells J. Biol. Chem. 283 2008 24145 24154
35. F. Meric-Bernstam, and A.M. Gonzalez-Angulo Targeting the mTOR signaling network for cancer therapy J. Clin. Oncol. 17 2009 2278 2287
36. V. Meske, F. Alvert, and T.G. Ohm Coupling of mammalian target of rapamycin with phosphoinositide 3-kinase signaling pathway regulates protein phosphatase 2A-and glycogen synthase kinase-3β-dependent phosphorylation of tau J. Biol. Chem. 283 2008 100 109
37. T. Nemoto, T. Yanagita, S. Satoh, T. Maruta, T. Kanai, M. Murakami, and A. Wada Insulin-induced neurite-like process outgrowth: acceleration of tau protein synthesis via a phosphoinositide 3-kinase-mammalian target of rapamycin pathway Neurochem. Int. 59 2011 880 888
38. K.E. O'Reilly, F. Rojo, Q.B. She, D. Solit, G.B. Mills, D. Smith, H. Lane, F. Hofmann, D.J. Hicklin, D.L. Ludwig, J. Baselga, and N. Rosen MTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt Cancer Res. 66 2006 1500 1508
39. T. Pan, S. Kondo, W. Zhu, W. Xie, J. Jankovic, and W. Le Neuroprotection of rapamycin in lactacystin-induced neurodegeneration via autophagy enhancement Neurobiol. Dis. 32 2008 16 25
40. M. Raman, W. Chen, and M.H. Cobb Differential regulation and properties of MAPKs Oncogene 26 2007 3100 3112
41. Q.G. Ren, X.M. Liao, X.Q. Chen, G.P. Liu, and J.Z. Wang Effects of tau phosphorylation on proteasome activity FEBS Lett. 581 2007 1521 1528
42. R.C. Russell, C. Fang, and K.L. Guan An emerging role for TOR signaling in mammalian tissue and stem cell physiology Development 138 2011 3343 3356
43. D.J. Selkoe Alzheimer's disease is a synaptic failure Science 298 2002 789 791
44. J.B. Shabb Physiological substrates of cAMP-dependent protein kinase Chem. Rev. 101 2001 2381 2411
45. B.S. Skalhegg, and K. Tasken Specificity in the cAMP/PKA signaling pathway. Differential expression, regulation, and subcellular localization of subunits of PKA Front. Biosci. 2 1997 331 342
46. C.J. Smith, B.H. Anderton, D.R. Davis, and J.M. Gallo Tau isoform expression and phosphorylation state during differentiation of cultured neuronal cells FEBS Lett. 375 1995 243 248
47. I. Sotiropoulos, C. Catania, T. Riedemann, J.P. Fry, K.C. Breen, T.M. Michaelidis, and O.F. Almeida Glucocoriticoids trigger Alzheimer disease-like pathobiochemistry in rat neuronal cells expressing human tau J. Neurochem. 107 2008 385 397
48. A. Soulard, A. Cremonesi, S. Moes, F. Schutz, P. Jeno, and M.N. Hall The rapamycin-sensitive phosphoproteome reveals that TOR controls protein kinase A toward some but not all substrates Mol. Biol. Cell. 21 2010 3475 3486
49. L. Sun, X. Wang, S. Liu, Q. Wang, J. Wang, M. Bennecib, C.X. Gong, A. Sengupta, I. Grundke-Iqbal, and K. Iqbal Bilateral injection of isoproterenol into hippocampus induces Alzheimer-like hyperphosphorylation of tau and spatial memory deficit in rat FEBS Lett. 579 2005 251 258
50. J. Sunayama, K. Matsuda, A. Sato, K. Tachibana, K. Suzuki, Y. Narita, S. Shibui, K. Sakuarada, T. Kayama, A. Tomiyama, and C. Kitanaka Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cell Stem Cells 28 2010 1930 1939
51. T. Tanaka, K. Iqbal, E. Trenkner, D.J. Liu, and I. Grundke-Iqbal Abnormally phosphorylated tau in SY5Y human neuroblastoma cells FEBS Lett. 360 1995 5 9
52. Q.Q. Tang, M. Gronborg, H. Huang, J.W. Kim, T.C. Otto, A. Pandey, and M.D. Lane Sequential phosphorylation of CCAAT enhancer-binding protein beta by MAPK and glycogen synthase kinase 3beta is required for adipogenesis Proc. Natl. Acad. Sci. USA 102 2005 766 9771
53. Y. Tatebayashi, K. Iqbal, and I. Grundke-Iqbal Dynamic regulation of expression and phosphorylation of tau fibroblast growth factor-2 in neural progenitor cells from adult rat hippocampus J. Neurosci. 19 1999 5245 5254
54. M. Vaysberg, C.E. Balatoni, R.R. Nepomucemo, S.M. Krams, and O.M. Martinez Rapamycin inhibits proliferation of Epstein-Barr virus-positive B-cell lymphomas through modulation of cell-cycle protein expression Transplantation 83 2007 1114 1121
55. F. Vigneron, P. Dos Santos, S. Lemoine, M. Bonnet, L. Tariosse, T. Couffinhal, C. Duplaa, and B. Jaspard-Vinassa GSK-3β at the crossroads in the signaling of heart preconditioning: implication of mTOR and Wnt pathways Cardiovasc. Res. 90 2011 49 56
56. H. Viola, M. Furman, L.A. Izquierdo, M. Alonso, D.M. Barros, M.M. de Souza, I. Izquierdo, and J.H. Medina Phosphorylated cAMP response element-binding protein as a molecular marker of memory processing in rat hippocampus: effect of novelty J. Neurosci. 20 2000 112
57. O.V. Vitolo, A. Sant' Angelo, V. Costanzo, F. Battaglia, O. Arancio, and M. Shelanski Amyloid β-peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling Proc. Natl. Acad. Sci USA 99 2002 13217 13221
58. J.Z. Wang, I. Grundke-Iqbal, and K. Iqbal Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration Eur. J. Neurosci. 25 2007 59 68
59. A. Williams, L. Jahreiss, S. Sarkar, S. Saiki, F.M. Menzies, B. Ravikumar, and D.C. Rubinsztein Aggregate-prone proteins are cleared from the cytosol by autophagy: therapeutic implications Curr. Top. Dev. Biol. 76 2006 89 101
60. 2± and by rapid desensitization J. Neurochem. 63 1994 177 185
61. Y. Zhang, H.L. Li, D.L. Wang, S.J. Liu, and J.Z. Wang A transitory activation of protein kinase-A induces sustained tau hyperphosphorylation at multiple sites at N2a cells-imply a new mechanism in Alzheimer pathology J. Neural. Transm. 113 2006 1487 1497